Actively Recruiting
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
Led by Fudan University · Updated on 2024-09-19
276
Participants Needed
3
Research Sites
171 weeks
Total Duration
On this page
Sponsors
F
Fudan University
Lead Sponsor
S
Shanghai Weihe Medical Laboratory Co., Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is a multi-center, observational study aiming at developing a machine learning-based early detection model using prospectively collected liquid biopsy samples from clinically-annotated individuals.
CONDITIONS
Official Title
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 40 and 75 years
- Clinically or pathologically diagnosed pancreatic cancer or benign pancreatic disease
- No prior or current systemic or local antitumor therapy including surgery, radiochemotherapy, endocrinotherapy, targeted therapy, immunotherapy, or interventional therapy
- Able to provide written informed consent and willing to follow all study procedures
You will not qualify if you...
- Pregnancy or lactating women
- Known prior or current diagnosis of other types of cancers
- Severe acute infection or febrile illness (temperature ≥ 38.0 °C) within 14 days before blood draw
- Organ transplant recipients or prior bone marrow/stem cell transplant
- Blood transfusion within 30 days before blood draw
- Therapy with antibiotics, glucocorticoids, or other specified drugs within 14 days before blood draw
- Any other conditions deemed unsuitable by investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
2
Department of Hepato-Biliary-Pancreatic-Splenic Surgery, Shanghai General Hospital
Shanghai, Shanghai Municipality, China, 200080
Actively Recruiting
3
Department of General Sugery, Huadong Hospital
Shanghai, Shanghai Municipality, China
Actively Recruiting
Research Team
X
Xian-Jun Yu, M.D., Ph.D.
CONTACT
S
Si Shi, M.D., Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here